Related Experiment Videos
Recombinant blood clotting proteins for hemophilia therapy
S A Limentani1, D A Roth, B C Furie
1Division of Hematology-Oncology, New England Medical Center, Boston, MA 02111.
Seminars in Thrombosis and Hemostasis
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Behavior of major and trace elements in a transient surface water/groundwater system following removal of a long-term wastewater treatment facility source.
The Science of the total environment·2019
Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.
Journal of thrombosis and haemostasis : JTH·2018
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
Thromboelastography Parameters Thresholds for Optimal Prediction of Major Bleeding after On-Pump Cardiac Surgery.
Seminars in thrombosis and hemostasis·2026
The Historical Painting of the "Bleeding Woman": Its Relevance for Today and the Future.
Seminars in thrombosis and hemostasis·2026
The Evolving Knowledge on Primary Hemostasis in Neonates.
Seminars in thrombosis and hemostasis·2026
Interim Efficacy Analysis of Different Anticoagulation Regimens in Patients with Long-Term Implantation of Inferior Vena Cava Filter.
Seminars in thrombosis and hemostasis·2026
PAI-1 as a Therapeutic Target: A State-of-the-Art Review.
Seminars in thrombosis and hemostasis·2026
Prognostic Role of Blood Inflammatory Composite Biomarkers in Dvt After Lower Extremity Fractures.
The Iowa orthopaedic journal·2026
Pattern of blood utilization and blood wastage at blood bank of a tertiary care hospital in Lahore.
Pakistan journal of medical sciences·2026
Coagulation potential of concomitant factor VIII administration in people with hemophilia A receiving emicizumab prophylaxis (CAGUYAMA study): a multicenter, open-label, nonrandomized clinical trial.
Research and practice in thrombosis and haemostasis·2026
Management and outcomes in patients with cryptogenic stroke and weakly positive antiphospholipid antibodies.
Research and practice in thrombosis and haemostasis·2026